Stockscreener 앱 받기
2.38
1.65%
-0.04
시간 외 거래:
2.35
-0.03
-1.26%
Avalon Globocare Corp 주식(ALBT)의 최신 뉴스
What analysts say about Avalon GloboCare Corp. stockFree Bull & Bear Market Updates - Autocar Professional
Avalon GloboCare enters agreement to sell $300,000 in Series C preferred stock - Investing.com
Avalon GloboCare enters agreement to sell $300,000 in Series C preferred stock By Investing.com - Investing.com South Africa
Avalon GloboCare Secures $300,000 in Preferred Stock Deal - TipRanks
What drives Avalon GloboCare Corp. stock priceExceptional risk-adjusted gains - Autocar Professional
Avalon GloboCare Corp. Stock Analysis and ForecastHigh-yield portfolio picks - jammulinksnews.com
Is Avalon GloboCare Corp. a good long term investmentFree High-Return Strategy Alerts - Autocar Professional
Avalon GloboCare Shares Rise After Gaining New Patent for CAR-T Cell Technology in Hong Kong - MSN
Avalon GloboCare Closes Securities Purchase Agreement - TipRanks
Why Avalon GloboCare Corp. stock attracts strong analyst attentionSmall Risk Large Return Trades - Newser
What makes Avalon GloboCare Corp. stock price move sharplyInsider Level Guidance - Newser
How Avalon GloboCare Corp. stock performs during market volatilityCapital Safe Smart Trades - Newser
Avalon GloboCare Secures Patent for CAR-T Technology - TipRanks
ALBT Shares Surge 12% Amidst Positive Market Momentum - StocksToTrade
ALBT: Recent Surge Leaves Investors Asking What’s Next? - timothysykes.com
Avalon GloboCare stock soars after securing new CAR-T cell patent - Investing.com Nigeria
Avalon GloboCare stock soars after securing new CAR-T cell patent By Investing.com - Investing.com South Africa
Avalon GloboCare Receives Hong Kong Patent for Advanced CAR-T, CAR-NK Cell Technology - MarketScreener
Avalon GloboCare secures Hong Kong patent for CAR-T cell technology - Investing.com
Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong - The Manila Times
Avalon GloboCare Corp. Secures Patent for Proprietary CAR-T and CAR-NK Cell Technology in Hong Kong - Nasdaq
Breakthrough CAR-T Cell Therapy Patent Secures 20-Year Protection in Hong Kong Market - Stock Titan
Avalon GloboCare Issues Convertible Promissory Notes - TipRanks
Avalon GloboCare issues $200,000 in convertible notes to investors By Investing.com - Investing.com
0.36%
0.68%
자본화:
|
볼륨(24시간):